Opko Health Buys Bio-Reference in $1.5 Billion All-stock Transaction

Bio-Reference Laboratories is the third-largest full service clinical laboratory in the United States.

comments Print
Opko Health, the U.S. drug-development company traded on the Tel Aviv Stock Exchange, said yesterday it had agreed to buy clinical laboratory operator Bio-Reference Laboratories in a stock deal valued at $1.47...